Next Article in Journal
Bioactive Alkaloids from the Mangrove-Derived Fungus Nigrospora oryzae SYSU-MS0024
Next Article in Special Issue
Denigrins H–L: Sulfated Derivatives of Denigrins D and E from a New Zealand Dictyodendrilla c.f. dendyi Marine Sponge
Previous Article in Journal
A Hadal Streptomyces-Derived Echinocandin Acylase Discovered through the Prioritization of Protein Families
Previous Article in Special Issue
Chemical Investigation of the Calcareous Marine Sponge Pericharax heteroraphis, Clathridine-A Related Derivatives Isolation, Synthesis and Osteogenic Activity
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Spongia Sponges: Unabated Sources of Novel Secondary Metabolites

College of Chemistry and Chemical Engineering, Central South University of Forestry and Technology, Changsha 410004, China
*
Author to whom correspondence should be addressed.
Mar. Drugs 2024, 22(5), 213; https://doi.org/10.3390/md22050213
Submission received: 31 March 2024 / Revised: 27 April 2024 / Accepted: 4 May 2024 / Published: 7 May 2024
(This article belongs to the Special Issue Bio-Active Components from Marine Sponges)

Abstract

:
Marine sponges of the genus Spongia have proven to be unabated sources of novel secondary metabolites with remarkable scaffold diversities and significant bioactivities. The discovery of chemical substances from Spongia sponges has continued to increase over the last few years. The current work provides an up-to-date literature survey and comprehensive insight into the reported metabolites from the members of the genus Spongia, as well as their structural features, biological activities, and structure–activity relationships when available. In this review, 222 metabolites are discussed based on published data from the period from mid-2015 to the beginning of 2024. The compounds are categorized into sesquiterpenes, diterpenes, sesterterpenes, meroterpenes, linear furanoterpenes, steroids, alkaloids, and other miscellaneous substances. The biological effects of these chemical compositions on a vast array of pharmacological assays including cytotoxic, anti-inflammatory, antibacterial, neuroprotective, protein tyrosine phosphatase 1B (PTP1B)-inhibitory, and phytoregulating activities are also presented.

1. Introduction

Marine natural products are an enormous source of potentially novel and biologically active compounds [1]. They are frequently developed as lead compounds and drugs [2,3], such as for anticancer [4,5], antimalarial [6], and human immunity purposes [7]. They can also be used as cosmetic ingredients [8], insecticides [9], and environmentally friendly antifoulants [10]. Among the various marine organisms, marine sponges of the order Dictyoceratida have been proven to be a remarkable biochemical warehouse for marine natural products [11,12].
The genus Spongia belongs to the family Spongidae of the order Dictyoceratida and comprises three subgenera, Australospongia, Heterofibria, and Spongia, containing 1, 7, and 81 species, respectively. To provide a full-aspect and in-depth view on novel secondary metabolites of Spongia sponges, Patrícia Máximo et al. published the first review of this genus entitled ‘‘The role of Spongia sp. in the discovery of marine lead compounds’’ in 2016. In the previously mentioned review, the sources, chemical structures, and bioactivities of 306 compounds were described from the sponges of the genus Spongia from 1971 to early 2015 [13]. Following the rapid development of marine natural products research, more and more secondary metabolites from Spongia sponges have been reported in recent years. As outlined in an extensive literature survey, 222 metabolites were obtained from different species of the genus Spongia from mid-2015 to the beginning of 2024. So many compounds reported in such a short period revealed the demand for an up-to-date review.
In this review, the secondary metabolites of Spongia sponges displayed a remarkable array of complex molecular architectures, which could be divided into eight groups, including sesquiterpenes, diterpenes, sesterterpenes, meroterpenes, linear furanoterpenes, steroids, alkaloids, and other miscellaneous. And these isolates were subjected to a wide spectrum of bioassays, such as cytotoxic, anti-inflammatory, antibacterial, neuroprotective, PTP1B inhibitory, and phytoregulating activities. Herein, the metabolites of the members of this genus Spongia, as well as their structural features, biological activities, and structure–activity relationships, when available, are presented.

2. Sesquiterpenes

This class of compounds is referred to as sesquiterpenes or norsesquiterpenes without an additional non-terpenoidal subunit (Figure 1).
A study on the Chinese sponge Spongia sp. led to the discovery of a pair of new valerenane sesquiterpene enantiomers, (+)- and (−)-spongiterpene [(+)-1 and (−)-1], along with two C11 nor-sesquiterpenes, dehydrololiolide (2) and loliolide (3), and two C13 nor-sesquiterpenes, dehydrovomifoliol (4) and 3β-hydroxy-5α,6α-epoxy-7-megastimen-9-one (5). It might be worth pointing out that quantum chemical ECD calculations were applied to determine the absolute configurations of (+)-1 and (−)-1. The cytotoxic activities of (+)-1 and (−)-1 were evaluated against several cancer cells including K562, A549, Hela, HT29, SK-BR-3, Huh7, RBL-2H3 and PC3. However, (+)-1 and (−)-1 showed no anti-proliferative effects on these carcinoma cells at 100 μM [14]. An investigation involving the Red Sea sponge Spongia sp. afforded pacifenol (6), which is a trihalogenated sesquiterpene with a chamigrane skeleton. This was the first report of pacifenol (6) in the sponge. This compound was subjected to several bioassays including cytotoxicity against the Huh7 cell line, antibacterial activity against Staphylococcus aureus, and anti-inflammatory activity. However, it was inactive in these biotests [15].

3. Diterpenes

Diterpenes are the most abundant terpenes found in Spongia sponges. Of which, spongian is the characteristic type of diterpene and this name reflects the origin of the early examples of this class of diterpene in the sponge genus Spongia [16]. In this work, most of the spongian diterpenes were tetracyclic, containing a furan ring. In some cases, the furan was replaced with an unsaturated γ-lactone or γ-lactam or a γ-hydroxybutenolide. Especially intriguing members of this group are degraded, ring contracted, or seco-diterpenes (Figure 2).
An investigation involving the Indonesian marine sponge Spongia ceylonensis disclosed the presence of six new nitrogenous spongian diterpenes, ceylonamides A–F (712), and one new spongian diacetal, 15α,16-dimethoxyspongi-13-en-19-oic acid (13), together with eight known terpenes 1421. These secondary metabolites were evaluated for their inhibitory effects on the RANKL-induced formation of multinuclear osteoclasts in RAW264 macrophages. The results revealed that ceylonamides A (7) and B (8) exhibited significant inhibitory activities (IC50 = 13 and 18 μM, respectively), whereas the IC50 values of the other compounds, 921, were more than 50 μM. Inspection of the structure–activity relationships of these isolates inferred that the position of the carbonyl group of the γ-lactam ring and bulkiness of the substituent at its nitrogen atom played important roles in the inhibitory properties [17].
Research on another specimen of Indonesian marine sponge S. ceylonensis led to the isolation of six new spongian diterpene derivatives, ceylonins A–F (2227), as well as the previously reported compound 19. Interestingly, these new compounds harbored three additional carbons in ring D to generate an ether-bridged bicyclic ring system. The absolute configurations of these newly discovered terpenes were elucidated based on the comparison of the calculated ECD spectra with the corresponding experimental ones. The bicyclic ring system might be derived from the major metabolite 19 and a C3 unit (an acrylic acid equivalent) through an intermolecular Diels–Alder reaction, which was experimentally supported by the transformation of 19 and acrylic acid to 2227. The inhibitory effects of all of the isolates on the RANKL-induced formation of multinuclear osteoclasts in RAW264 macrophages were examined. Among them, 22 significantly inhibited the formation of multinuclear osteoclasts by 70% in a dose-dependent manner without cytotoxicity, followed by 26 (47%), 27 (31%), and 25 (28%). However, the major compound 19 did not inhibit the formation of multinuclear osteoclasts at 50 μM [18]. From the view of structure–activity relationships, the ether-bridged bicyclic ring system was likely a key functionality for the bioactivity. Further purification of the above-mentioned sample afforded three new spongian diterpenes, ceylonins G–I (2830), together with known compound ent-13-norisocopalen-15-al-18-oic acid (31), in addition to the five previously reported ones 1518. The absolute configurations of these new substances were determined via ECD calculations. In this work, the ubiquitin-specific protease 7 (USP7) inhibitory activities of compounds 712, 1519, and 2231 were evaluated. As a result, only 31 inhibited USP7 with an IC50 value of 8.2 μM, while the IC50 values of the other compounds were more than 50 μM. The substructure including an aldehyde group at the C-ring in 31 may be important for this inhibition [19].
The South China Sea sponge Spongia officinalis afforded eight metabolic components including three new diterpenes 3-nor-spongiolide A (32) and spongiolides A (33) and B (34), along with six related known ones, 3540. Notably, compound 32 possessed the extremely rare 3-nor-spongian carbon architecture. ECD calculations were employed to assign the absolute configurations of three new substances, 3234. In the cytotoxic bioassay, none of these isolates exhibited potent cytotoxic activity against HL-60 cell lines [20]. Spongiains A–G (4147) were yielded by the Chinese marine sponge Spongia sp. Intriguingly, compounds 4143 were the first examples of spongian diterpenes bearing a pentacyclic skeleton composed of a fused 5/5/6/6/5 ring system derived from ring A rearrangement. X-ray diffraction experiments and quantum chemical approaches were used to establish the absolute configurations of new metabolites 4147. These natural products were inactive against an array of cancer cells (K562, A549, Hela, HT29, SK-BR-3, Huh7, RBL-2H3, and PC3) in the anti-proliferative bioassay. Nevertheless, 42 and 43 were able to promote the proliferation of RBL-2H3 cells in dose-dependent concentrations between 10 and 80 μM [21].
An unprecedented 5,5,6,6,5-pentacyclic diterpene, sponalactone (48), two new spongian diterpenes, 17-O-acetylepispongiatriol (49) and 17-O-acetylspongiatriol (50), and two new spongian diterpene artifacts, 15α,16α-dimethoxy-15,16-dihydroepispongiatriol (51) and 15α-ethoxyepispongiatriol-16(15H)-one (52), together with previously found metabolites 3739, were obtained from another specimen of South China Sea sponge S. officinalis. The absolute configurations of these new compounds were assigned on the basis of ECD data. In the primary screening, compounds 38 and 4852 displayed moderate inhibition against lipopolysaccharide (LPS)-induced nitric oxide (NO) production in RAW264.7 macrophages with IC50 values of 12–32 μM, whereas no inhibitory effect was observed for 39 (IC50 > 60 μM). The weaker activities of 39 and 48 in comparison with 38 and 4952 suggested that 2-oxo-3-hydroxycyclohexane was an essential substructure in ring A for inhibitory activity [22].
Purification of the extract of the Indonesian marine sponge of Spongia sp. led to the discovery of three new nitrogenous diterpenes, designated ceylonamides G–I (5355), together with ceylonamide F (12). Among these marine natural products, 12 and 53 inhibited the proliferation of DU145 cells (IC50 = 18.8 and 6.9 µM, respectively) in a two-dimensional monolayer culture. Furthermore, these compounds were also effective on the spheroid of the three-dimensional DU145 cell culture model, with the minimum effective concentrations being 10 and 25 µM, respectively [23]. The search for the chemical composition of the Mexican sponge Spongia tubulifera resulted in the isolation and identification of two new spongian furanoditerpenes, 3β-hydroxyspongia-13(16),14-dien-2-one (56) and 19-dehydroxy-spongian diterpene 17 (57), along with four known terpenes, 5861. The absolute configurations of two new substances were determined through a comparison of the experimental ECD spectra with those calculated using time-dependent density functional theory (TDDFT). Weak cytotoxicities against the A549, A2058, HepG2, MCF7, and MiaPaca-2 cell lines (with IC50 values ranging from 91.3 to 11.7 µM) were observed for components 56, 59, and 61. However, none of the metabolites showed any significant antibacterial activity against four bacteria Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and S. aureus or potent antiviral activity against human HAdV5 and HAdV5-GFP adenoviruses [24]. A recent study indicated that diterpenes 5660 displayed mitochondrial-mediated neuroprotective properties through direct interaction with cyclophilin D [25].
Dinorspongians A–F (6267) and epoxynorspongians A–F (6873) were found as twelve new metabolic compositions of a Chinese sponge Spongia sp. Structurally, compounds 6267 were unprecedented dinorspongian diterpenes with a 3,4-seco-3,19-dinorspongian carbon framework, and 6873 were the first reported 19-norspongian diterpenes with a 5,17-epoxy unit. The absolute configurations of these compounds were established through X-ray diffraction and quantum chemical calculation, respectively. The anti-proliferation properties of 6273 against the HeLa, Huh7, RBL-2H3, and PC3 cell lines were evaluated. As a result, compound 72 showed moderate activity against the PC3 and PBL-2H3 cell lines (IC50 = 24.8 and 27.2 μM, respectively) [26]. A Red Sea Spongia sp. afforded a new 2,4-cyclized-3,4-secospongian diterpenoid, 17-dehydroxysponalactone (74), and a known norditerpene, 18-nor-3,17-dihydroxy-spongia-3,13(16),14-trien-2-one (75). Component 74 was found to be inactive in the cytotoxic bioassay against the P388, HuCCT, DLD-1, and CCD-966SK cell lines. However, it exhibited potent activity to inhibit superoxide anion (O2) generation and elastase release (IC50 = 3.37 ± 0.21 and 4.07 ± 0.60 μM, respectively) [27].
A chemical investigation involving the aquaculture sponge S. officinalis yielded two new secondary metabolites 2β,3α,19-triacetoxy-17-hydroxyspongia-13(16),14-diene (76) and 18-nor-2,17-hydroxyspongia-1,4,13(16),14-quaien-3-one (77), together with six related known metabolites, 39, 75, and 7881. Quantum chemical calculations of NMR parameters and ECD were employed to determine the absolute configurations of two new isolates, 76 and 77. All isolated compounds were evaluated for cytotoxicity against the K562, H69AR, ASPC-1, and MDA-MB-231 cell lines. Among them, constituents 75, 76, and 78 displayed cytotoxic activities against K562 (IC50 = 3.5, 7.3, and 6.4 μM, respectively), and 78 exhibited cytotoxicity against H69AR (IC50 = 9.5 μM). The signaling inhibition of HIF-1, Wnt, and STAT3/NF-κB and the activation of PPARγ/p53 of all isolated compounds were also evaluated. At the concentration of 20 μM, substances 75 and 78 displayed remarkable Wnt and HIF-1 inhibitory activity with inhibitory rates ranging from 88.5% to 84.7% [28]. The presence of an unreported bicyclic diterpenoid with an unprecedented penta-substituted carbon architecture, jellynolide A (82), was revealed in a further investigation involving the aquaculture sponge S. officinalis. Its absolute configuration was established through quantum chemical calculations of NMR parameters and ECD, too. Diterpene 82 was subjected to an array of bioassays including cytotoxicity against the K562, ASPC-1, MDA-MB-231, and H69AR cell lines, antipolymerase activities against COVID-19 RNA-dependent RNA polymerase, signaling inhibition of HIF-1, Wnt, STAT3/NF-κB, and activation of PPARγ/p53. As a result, 82 only showed obvious inhibition against HIF-1 and STAT3/NF-κB with inhibitory rates of 67.6% and 71.6% at 20 μM, respectively [29].
A new dinorspongian diterpene, dinorspongiapyridine (83), was reported as the chemical constituent of a South China Sea marine sponge Spongia sp. Metabolite 83 was the first member of the 3,4-seco-3,19-dinorspongian diterpene with a rare pyridyl D-ring system. Its structure along with absolute configuration was confirmed via X-ray diffraction. The anti-proliferative effects of 83 were evaluated against the K562, A549, Hela, HT29, SK-BR-3, and Huh7 cell lines. However, 83 showed no cytotoxicity against these cells at the concentration of 50 μmol/L [30].
In addition to 54, 19,20-dihydroxyspongia-13(16),14-diene (84), 3β-acetoxyspongia-13(16),14-diene (85), and 3α-acetoxyspongia-13(16),14-diene (86) were identified as the chemical compositions of Red Sea marine sponge Spongia irregularis. The binding affinity of these compounds to different targets for HCV was examined via molecular docking experiments. However, the results revealed that none of them had obvious inhibitory potential [31]. A cemical investigation involving a sample of Red Sea sponge Spongia sp. led to the discovery of a new diterpene, spongianol (87), and a known one, 10-hydroxykahukuene B (88). The new compound 87 was a polyoxygenated and halogenated labdane diterpenoid, whose absolute configuration was established via the ECD calculation approach. The brominated diterpene 88 represented the first example of a natural product with a prenylated chamigrane skeleton that had been isolated from the sponge. In the cytotoxic bioassay, only compound 88 showed weak cytotoxicity against Huh7 cell lines (inhibitory rate of 17% at 50 µM). However, both terpenes were inactive in the screening experiments of antibacterial activity against S. aureus and anti-inflammatory activity [15].
Another study on a Red Sea sponge Spongia sp. showed the presence of three new diterpenes named spongenolactones A–C (8991). Compounds 8991 were the first reported 5,5,6,6,5-pentacyclic spongian diterpenes with an β-hydroxy group at C-1. The anti-proliferative effects of 8991 against the Huh7 cell line were evaluated. However, none of them showed notable cytotoxic activity against this cancer cell line, whereas 89 and 90 displayed weak antibacterial properties against S. aureus and weak inhibition of O2 generation in the corresponding bioassays [32]. Further chemical investigation of this sponge revealed the discovery of four new 3,4-seco-3,19-dinorspongian lactones, secodinorspongins A–D (9295), along with a spongian lactone, sponginolide (96). The absolute configurations of compounds 92 and 9496 were established through a comparison of the experimental and calculated ECD spectra. Compound 92 exhibited antibacterial activity against S. aureus and compounds 95 and 96 displayed anti-inflammatory effect in the suppression of O2 [33].

4. Sesterterpenes

All of the sesterterpenes of the genus Spongia possess a carbon skeleton named scalarane, which is a tetracyclic carbon architecture of four fused six-membered rings (Figure 3). In some cases, sesterterpenoids have ring E and form a pentacyclic system.
Two new scalarane-type sesterterpenes 97 and 98 were identified as chemical compositions of the Korean marine sponge Spongia sp. They were tested for their farnesoid X-activated receptor (FXR) antagonistic and cytotoxic activities. However, neither of them were active [34]. For the Bornean sponge Spongia sp., scalarolide acetate (99), scalarolide (100), 12-O-deacetyl-12-epi-19-O-methylscalarin (101), and methyl 18-hydroxy-19-norscalar-16-en-20-carboxylate (102) were reported as its metabolic components. Metabolites 99101 exhibited strong cytotoxic activities against adult T-cell leukemia, S1T cells [35].
A further study on the chemical compositions of Korean marine sponge Spongia sp. resulted in the discovery of four new scalarane sesterterpenes named scalalactams A–D (103106). These terpenes were characterized by an isopentanyl alcohol or a phenylethyl group substituted at the lactam ring. All of them were inactive in the FXR antagonistic and cytotoxic bioassays [36]. The Mexican marine sponge S. tubulifera afforded scalarin (107). This substance was evaluated for cytotoxic activity against the A549, A2058, HepG2, MCF7, and MiaPaca-2 cell lines, antibacterial activity against A. baumannii, P. aeruginosa, K. pneumoniae, and S. aureus, and antiviral activity against human HAdV5 and HAdV5-GFP adenoviruses. However, no obvious bioactivity was observed in these bioassays [24].
Twelve unreported scalaranes, namely scalimides A–L (108119), were found in the Philippine marine sponge Spongia sp. These constituents furnished a lactam ring with different degrees of oxidation and substitutions. All of them were evaluated for antibacterial activity against the Gram-positive bacteria Micrococcus luteus and S. aureus and Bacillus subtilis and the Gram-negative bacteria Salmonella typhimurium, K. pneumoniae, and Escherichia coli. As a result, only compound 117 was active against all bacteria, with MIC values ranging from 4 to 64 μg/mL. Moreover, components 108119 exhibited moderate anticancer effects against MCF7, with EC50 values ranging from 13.7 to 73.9 μM [37].
12-Deacetoxy-4-demethyl-11,24-diacetoxy-3,4-methylenedeoxoscalarin (120) was a new sesterterpene yielded by the Indonesian marine sponge Spongia cf. agaricina. This substance featured the fusion of a cyclopropane ring and ring A and displayed antibacterial activity against Arthrobacter crystallopoietes and Bacillus megaterium [38].

5. Meroterpenes

This category of terpenes are the hybrids of sesquiterpenes and quinones or phenols, except for smenospongic acid, which is a degradation product (Figure 4).
Three meroterpenes, isospongiaquinone (121), ilimaquinone (122), and smenoquinone (123), were isolated from the South China Sea marine sponge Spongia sp. Components 121 and 122 exhibited phytoregulating activity for agricultural plants [39]. An investigation involving the South China Sea marine sponge Spongia pertusa led to the discovery of nine new secondary metabolites, 124130, 133, and 135, three artifacts, 131, 132, and 134, and three known compounds, 136138. Their absolute configurations were established through comparisons of experimental and calculated ECD spectra. All of these components were evaluated for cytotoxicities against the U937, A549, HeLa, and HepG2 cell lines. The results showed that metabolites 136138 exhibited the most potent cytotoxic activities against U937 (IC50 = 2.8, 1.5, and 0.6 μM, respectively). Additionally, 129 exhibited CDK-2 affinity (Kd = 4.8 μM) [40]. Further in-depth study disclosed that smenospongine (137) preferentially eliminates breast cancer stem-like cells via p38/AMPKα pathways [41].
Langcoquinones A (139) and B (140), along with four known meroterpenoids, 141144, in addition to the previously reported compounds 122, 137, and 138, were identified as the chemical compositions of the Vietnamese marine sponge Spongia sp. These components were assessed for antibacterial activities against B. subtilis, S. aureus, K. pneumoniae, and E. coli. As a result, 122, 141, 137, 138, and 144 displayed selective antibacterial activities against B. subtilis and S. aureus (MIC = 6.25–12.5 μM). As observed, the hydroxy group at C-14 led to the loss of antibacterial activity against the Gram-positive bacteria [42]. Four new meroterpenes, namely langconols A–C (145147) and langcoquinone C (148), as well as two known ones, 149 and 150, were identified in further studies on the sponge Spongia sp. The antibacterial assays indicated that 148 and 150 exhibited remarkable activity against B. subtilis and S. aureus (MIC = 6.25–25.0 μM, respectively), while 145 and 147 displayed strong antibacterial activities against B. subtilis (MICs = 12.5 and 25.0 μM, respectively). Moreover, isolates 122, 137140, 134, 147, 148, and 150 displayed significant cytotoxic activities against the HeLa, MCF7, A549, and WI-38 cell lines (IC50 = 3.0–9.7 μM) [43].
The Xisha marine sponge Spongia sp. afforded five meroterpenes, 150154, in addition to the previously reported 141. Compounds 150, 152, and 154 showed antifungal activities against Trichophyton rubrum, Trichophyton mentaqrophytes, and Candida albicans (MIC = 12.5–25 μg/mL) [44]. The Vietnamese sponge Spongia sp. yielded three metabolites, langcoquinones D–F (155157). Component 155 showed antibacterial effects against B. subtilis and S. aureus (MIC = 12.5 and 25.0 μM, respectively) and cytotoxic properties toward the HeLa, MCF7, A549, and WI-38 cell lines (IC50 = 8.6, 5.9, 8.9, and 5.6 μM, respectively) [45]. An investigation involving the Red Sea marine sponge S. irregularis disclosed the presence of four meroterpenes, 158161. Molecular docking calculations inferred the HCV inhibitory potential of 159 [31]. A study on the Aegean marine sponge Spongia sp. revealed the existence of five substances, 162166. Compound 163 exhibited the best cytotoxic activity toward AGS cells (IC50 = 0.99 μM) [46].
Purification of the extract of South China Sea marine sponge Spongia pertusa yielded two new merosesquiterpenoids, 167 and 168, together with nine known related analogs, 124, 125, 138, 144, 150, 152, 155, 169, and 170. The moderate antifungal activity of components 144, 150, 152, 155, and 170 against T. rubrum, T. mentaqrophytes, and C. albicans (MIC50 = 12.5–100 μg/mL) was observed [47]. Bioassay-guided fractionation of the extract of Japanese marine sponge Spongia (Heterofibria) sp. afforded two new sesquiterpene quinones, namely metachromins X (171) and Y (172), together with three known analogs, 173175. The structure of 171 was confirmed through total synthesis. The absolute configuration of 172 was determined through a combination of chiral HPLC and CD spectroscopy. All of these chemical constituents showed weak cytotoxicity against HeLa cells with (IC50 = 64, 76, 53, 73, and 89 μM, respectively). Additionally, 171 and 173 displayed arrest effects on the cell cycle progression of HeLa/Fucci2 cells at the S/G2/M phase [48].

6. Linear Furanoterpenoids

This group of terpenes do not possess a cyclic carbon ring but are composed of a furan ring. In some compounds, an additional γ-lactone or γ-lactam ring is present (Figure 5).
Demethylfurospongin-4 (176), furofficin (177), furospongin-1 (178), and spongialactams A (179) and B (180) have been reported as metabolic components of the Mediterranean marine sponge S. officinalis, which was recognized through untargeted LC–MS metabolomics and molecular networking [49]. Compound 178 was also found in the Indonesian marine sponge Spongia sp. This chemical constituent displayed PTP1B, TCPTP, and VHR inhibitory activities (IC50 = 9.9, 9.6 and 11 μM, respectively) [50]. The marine sponge S. officinalis collected off of Weizhou Island was found to be a source of furanoterpenes 181184 [51]. Further study on this species resulted in the discovery of two pairs of racemic furan butanolides, (±)-sponalisolides A (185) and B (186), which were characterized by an unprecedented furan-bearing alkyl chain connecting either a butanolide or an N-acyl homoserine lactone moiety. Biomimetic total synthesis was conducted to confirm their structures as well as absolute configurations unambiguously. All of the new compounds displayed quorum-sensing inhibitory activity against Pseudomonas aeruginosa [52].
The Red Sea marine sponge Spongia sp. Afforded three new compounds, 187189, and one known analogue, 190. These isolates did not exhibit cytotoxic against the P388, HuCCT DLD-1, and CCD-966SK cell lines. However, compound 190 was found to display significant inhibitory activity against O2 generation (IC50 = 5.31 ± 1.52 μM) [27]. The cultured sponge S. officinalis yielded six new chemical constituents, (±)-191-(±)-195 and (−)-196, as well as two previously reported compounds, (−)-187 and (±)-190. Notably, metabolites (±)-191-(±)-195 were four pairs of rare phosphate triesters. The absolute configurations of new isolates, 191195, were determined through quantum chemical calculations of NMR parameters and ECD. Moderate cytotoxicities against the MDA-MB-231, K562, and ASPC-1 cell lines (IC50 = 17.4, 28.0, and 11.0 μM, respectively) were observed for (+)-191. Moreover, (±)-192 displayed remarkable Wnt and HIF1 signaling inhibition [29].

7. Steroids

The Xisha sponge Spongia sp. afforded three unsaturated steroids, 197199 (Figure 6). Among them, compound 199 exhibited antifungal activity against T. rubrum (MIC = 25 μg/mL) [44]. The Red Sea sponge Spongia sp. yielded another unsaturated sterol, 200. This chemical constituent was evaluated for cytotoxicity against the P388, DLD-1, and CCD-966SK cell lines and the inhibition of O2 generation and elastase release. However, it displayed no obvious activity in the bioassays [27]. In a continuous study, two polyoxygenated steroids, 201 and 202, were identified. Intriguingly, 202 is the fourth steroid that possesses a rare seven-membered lactone B ring. The assignment of the absolute configuration of C-24 of the side chain in 201 was achieved based on the chemical shift differences of C-26 and C-27, which was further verified through a comparison of experimental and calculated ECD spectra. Neither of these two substances exhibited cytotoxicity against the Huh7 cell line or antibacterial activity against S. aureus or anti-inflammatory activity [15].

8. Alkaloids

This category of compounds is composed of true alkaloids and pseudoalkaloids. Biogenetically, the former are derived directly from amino acids, and the latter are derived from purine or other non-amino acids.
Two indole alkaloids, 203 and 204 (Figure 7), were isolated from the Korean marine sponge Spongia sp. They did not display obvious FXR inhibitory activity or cytotoxicity against CV-1 cells [53]. Compounds 205208 were reported to be metabolic components of the Red Sea sponge S. irregularis. Docking studies of these metabolites were carried out to evaluate their binding affinity to different targets for HCV. However, the results revealed that none of them had obvious inhibitory potential [31]. The Red Sea sponge Spongia sp. afforded amides 209 and 210, in addition to the previously reported amide 206. Chemical constituent 206 exhibited weak antibacterial activity against S. aureus, and chemical constituent 210 displayed weak cytotoxicity against Huh7 cells. Moreover, components 209 and 210 showed moderate elastase release inhibition (IC50 = 17.23 ± 2.45 and 14.60 ± 2.24 µM, respectively) [15].
The South China Sea marine sponge Spongia sp. is a source of alkaloids 207 and 211213 [30]. Further study on this sample resulted in the discovery of two new alkaloids, spongimides A (214) and B (215), along with five known ones, 216220. X-ray diffraction experiments confirmed the structures of two new compounds. Interestingly, 214, 215, and 217 are the first examples of 2,4-imidazolidinedione found in this genus. These two new chemical constituents did not exhibit cytotoxicity against the K562 cell line or antibacterial activities against Salmonella paratyphi and E. coli [54].

9. Other Miscellaneous Substances

Chemical investigation of the Red Sea sponge S. irregularis afforded 3,5-dihydroxyfuran-2(5H)-one (221) (Figure 8). Docking experiments revealed that this compound does not show obvious inhibitory effects against different targets of HCV [31]. A new α,β-unsaturated fatty acid, (Z)-3-methyl-9-oxodec-2-enoic acid (222), was found in the Red Sea sponge Spongia sp. This compound was subjected to several bioassays including cytotoxicity against the Huh7 cell line, antibacterial activity against S. aureus, and anti-inflammatory activity. However, it did not show any obvious activity [15].

10. Discussion

A total of 222 compounds from a variety of species of genus Spongia were reported from mid-2015 to the beginning of 2024, covering a period of nine years (Table S1). The substances illustrated in this work could be categorized as sesquiterpenes, diterpenes, sesterterpenes, meroterpenes, linear furanoterpenes, steroids, alkaloids, and other miscellaneous substances (Figure 9, Table S1). Most of these metabolites could be grouped into two major chemical classes: diterpenes and meroterpenes. Among them, diterpenes were the predominant chemical constituents, accounting for 40.5%, almost half of the total. These diterpenes were distinguished by their unique structural features, such as fused ring systems, stereochemical complexity, and functional group diversity.
Chemical investigations have been conducted on the species Spongia ceylonensis, Spongia officinalis, Spongia tubulifera, Spongia pertusa, Spongia cf. agaricina, Spongia irregularis, and unclearly identified Spongia sp. (Figure 10, Table S1). In terms of the number of isolated substances, except the unclearly identified Spongia sp., S. officinalis was the most prolific species, yielding 45 compounds. (Notably, some compounds were obtained in different species and were counted separately in each species).
As outlined in Figure 11 and Table S1, 222 metabolites were obtained from different species of the genus Spongia from mid-2015 to the beginning of 2024. This indicated that more than 20 secondary metabolites were afforded by the genus Spongia every year. Among these years, most compounds were found in the Spongia sponges in 2022. (Notably, some compounds were obtained in different years and were counted separately in each year).

11. Conclusions

As reported, some secondary metabolites, such as linear furanoterpenoids (±)-sponalisolides A (185) and B (186) [52], display fascinating structures, which makes them attractive targets for synthetic chemists. Moreover, some substances, for instance, spongian diterpenes 78 and 79 [28], exhibit significant activity including cytotoxic, anti-inflammatory, antibacterial, neuroprotective, and PTP1B inhibitory activities, which are worth further in-depth study by pharmacologists. So many compounds with distinct structural features and biological properties were reported in such a short period, indicating that Spongia sponges are unabated sources of novel secondary metabolites.
Due to the low yields of some important natural products from Spongia sponges, the exploration of silencing gene expression and large-scale fermentation for industry will likely be research hotspots in the future.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/md22050213/s1. Table S1: Secondary metabolites of the genus Spongia from mid-2015 to the beginning of 2024.

Author Contributions

Conceptualization, L.-F.L.; formal analysis, Q.-B.Y.; investigation, Q.-B.Y.; data curation, Q.-B.Y.; writing—original draft preparation, Q.-B.Y.; writing—review and editing, L.-F.L.; visualization, Q.-B.Y. and L.-F.L.; supervision, L.-F.L.; project administration, L.-F.L.; funding acquisition, L.-F.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China (No. 41876194).

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Carroll, A.R.; Copp, B.R.; Grkovic, T.; Keyzers, R.A.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2024, 41, 162–207. [Google Scholar] [CrossRef]
  2. Banerjee, P.; Mandhare, A.; Bagalkote, V. Marine natural products as source of new drugs: An updated patent review (July 2018–2021). Expert. Opin. Ther. Pat. 2022, 32, 317–363. [Google Scholar] [CrossRef]
  3. Haque, N.; Parveen, S.; Tang, T.; Wei, J.; Huang, Z. Marine natural products in clinical use. Mar. Drugs 2022, 20, 528. [Google Scholar] [CrossRef]
  4. Ren, X.; Xie, X.; Chen, B.; Liu, L.; Jiang, C.; Qian, Q. Marine natural products: A potential source of anti-hepatocellular carcinoma drugs. J. Med. Chem. 2021, 64, 7879–7899. [Google Scholar] [CrossRef]
  5. Khalifa, S.A.M.; Elias, N.; Farag, M.A.; Chen, L.; Saeed, A.; Hegazy, M.-E.F.; Moustafa, M.S.; Abd El-Wahed, A.; Al-Mousawi, S.M.; Musharraf, S.G.; et al. Marine natural products: A source of novel anticancer drugs. Mar. Drugs 2019, 17, 491. [Google Scholar] [CrossRef]
  6. Hai, Y.; Cai, Z.-M.; Li, P.-J.; Wei, M.-Y.; Wang, C.-Y.; Gu, Y.-C.; Shao, C.-L. Trends of antimalarial marine natural products: Progresses, challenges and opportunities. Nat. Prod. Rep. 2022, 39, 969–990. [Google Scholar] [CrossRef]
  7. Hu, C. Marine natural products and human immunity: Novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease. Nat. Prod. Bioprospect. 2024, 14, 12. [Google Scholar] [CrossRef]
  8. Fonseca, S.; Amaral, M.N.; Reis, C.P.; Custódio, L. Marine natural products as innovative cosmetic ingredients. Mar. Drugs 2023, 21, 170. [Google Scholar] [CrossRef]
  9. Song, C.; Yang, J.; Zhang, M.; Ding, G.; Jia, C.; Qin, J.; Guo, L. Marine natural products: The important resource of biological insecticide. Chem. Biodivers. 2021, 18, e2001020. [Google Scholar] [CrossRef]
  10. Liu, L.-L.; Wu, C.-H.; Qian, P.-Y. Marine natural products as antifouling molecules—A mini-review (2014–2020). Biofouling 2020, 36, 1210–1226. [Google Scholar] [CrossRef]
  11. Abdelaleem, E.R.; Samy, M.N.; Desoukey, S.Y.; Liu, M.; Quinn, R.J.; Abdelmohsen, U.R. Marine natural products from sponges (Porifera) of the order Dictyoceratida (2013 to 2019); a promising source for drug discovery. RSC Adv. 2020, 10, 34959–34976. [Google Scholar] [CrossRef]
  12. McCauley, E.P.; Piña, I.C.; Thompson, A.D.; Bashir, K.; Weinberg, M.; Kurz, S.L.; Crews, P. Highlights of marine natural products having parallel scaffolds found from marine-derived bacteria, sponges, and tunicates. J. Antibiot. 2020, 73, 504–525. [Google Scholar] [CrossRef]
  13. Máximo, P.; Ferreira, L.; Branco, P.; Lima, P.; Lourenço, A. The role of Spongia sp. in the discovery of marine lead compounds. Mar. Drugs 2016, 14, 139. [Google Scholar] [CrossRef]
  14. Liang, Y.-Q.; Liao, X.-J.; Zhao, B.-X.; Xu, S.-H. (+)- and (−)-Spongiterpene, a pair of new valerenane sesquiterpene enantiomers from the marine sponge Spongia sp. Nat. Prod. Res. 2021, 35, 2178–2183. [Google Scholar] [CrossRef]
  15. Tai, C.-J.; Ahmed, A.F.; Chao, C.-H.; Yen, C.-H.; Hwang, T.-L.; Chang, F.-R.; Huang, Y.M.; Sheu, J.-H. The chemically highly diversified metabolites from the Red Sea marine sponge Spongia sp. Mar. Drugs 2022, 20, 241. [Google Scholar] [CrossRef]
  16. Keyzers, R.A.; Northcote, P.T.; Davies-Coleman, M.T. Spongian diterpenoids from marine sponges. Nat. Prod. Rep. 2006, 23, 321–334. [Google Scholar] [CrossRef]
  17. El-Desoky, A.H.; Kato, H.; Angkouw, E.D.; Mangindaan, R.E.P.; de Voogd, N.J.; Tsukamoto, S. Ceylonamides A–F, nitrogenous spongian diterpenes that inhibit RANKL-induced osteoclastogenesis, from the marine sponge Spongia ceylonensis. J. Nat. Prod. 2016, 79, 1922–1928. [Google Scholar] [CrossRef]
  18. El-Desoky, A.H.; Kato, H.; Kagiyama, I.; Hitora, Y.; Losung, F.; Mangindaan, R.E.P.; de Voogd, N.J.; Tsukamoto, S. Ceylonins A–F, spongian diterpene derivatives that inhibit RANKL-induced formation of multinuclear osteoclasts, from the marine sponge Spongia ceylonensis. J. Nat. Prod. 2017, 80, 90–95. [Google Scholar] [CrossRef]
  19. El-Desoky, A.H.; Kato, H.; Tsukamoto, S. Ceylonins G–I: Spongian diterpenes from the marine sponge Spongia ceylonensis. J. Nat. Med. 2017, 71, 765–769. [Google Scholar] [CrossRef]
  20. Han, G.-Y.; Sun, D.-Y.; Liang, L.-F.; Yao, L.-G.; Chen, K.-X.; Guo, Y.-W. Spongian diterpenes from Chinese marine sponge Spongia officinalis. Fitoterapia 2018, 127, 159–165. [Google Scholar] [CrossRef]
  21. Liang, Y.-Q.; Liao, X.-J.; Lin, J.-L.; Xu, W.; Chen, G.-D.; Zhao, B.-X.; Xu, S.-H. Spongiains A-C: Three new spongian diterpenes with ring A rearrangement from the marine sponge Spongia sp. Tetrahedron 2019, 75, 3802–3808. [Google Scholar] [CrossRef]
  22. Chen, Q.; Mao, Q.; Bao, M.; Mou, Y.; Fang, C.; Zhao, M.; Jiang, W.; Yu, X.; Wang, C.; Dai, L.; et al. Spongian diterpenes including one with a rearranged skeleton from the marine sponge Spongia officinalis. J. Nat. Prod. 2019, 82, 1714–1718. [Google Scholar] [CrossRef]
  23. Jomori, T.; Setiawan, A.; Sasaoka, M.; Arai, M. Cytotoxicity of new diterpene alkaloids, ceylonamides G-I, isolated from Indonesian marine sponge of Spongia sp. Nat. Prod. Commun. 2019, 14, 1934578X19857294. [Google Scholar] [CrossRef]
  24. Pech-Puch, D.; Rodríguez, J.; Cautain, B.; Sandoval-Castro, C.A.; Jiménez, C. Cytotoxic furanoditerpenes from the sponge Spongia tubulifera collected in the Mexican Caribbean. Mar. Drugs 2019, 17, 416. [Google Scholar] [CrossRef]
  25. Alvariño, R.; Alfonso, A.; Pech-Puch, D.; Gegunde, S.; Rodríguez, J.; Vieytes, M.R.; Jiménez, C.; Botana, L.M. Furanoditerpenes from Spongia (Spongia) tubulifera display mitochondrial-mediated neuroprotective effects by targeting cyclophilin D. ACS Chem. Neurosci. 2022, 13, 2449–2463. [Google Scholar] [CrossRef]
  26. Liang, Y.-Q.; Liao, X.-J.; Zhao, B.-X.; Xu, S.-H. Novel 3,4-seco-3,19-dinorspongian and 5,17-epoxy-19-norspongian diterpenes from the marine sponge Spongia sp. Org. Chem. Front. 2020, 7, 3253–3261. [Google Scholar] [CrossRef]
  27. Tai, C.-J.; Huang, C.-Y.; Ahmed, A.F.; Orfali, R.S.; Alarif, W.M.; Huang, Y.M.; Wang, Y.-H.; Hwang, T.-L.; Sheu, J.-H. An anti-inflammatory 2,4-cyclized-3,4-secospongian diterpenoid and furanoterpene-related metabolites of a marine sponge Spongia sp. from the red sea. Mar. Drugs 2021, 19, 38. [Google Scholar] [CrossRef]
  28. Jin, T.; Li, P.; Wang, C.; Tang, X.; Yv, X.; Li, K.; Luo, L.; Ou, H.; Li, G. Two new spongian diterpene derivatives from the aquaculture sponge Spongia officinalis Linnaeus, 1759. Nat. Prod. Res. 2023, 37, 216–226. [Google Scholar] [CrossRef]
  29. Jin, T.; Li, P.; Wang, C.; Tang, X.; Yu, X.; Sun, F.; Luo, L.; Ou, H.; Li, G. Jellynolide A, pokepola esters, and sponalisolides from the aquaculture sponge Spongia officinalis L. Phytochemistry 2022, 194, 113006. [Google Scholar] [CrossRef]
  30. Liang, Y.; Liao, X.; Ling, L.; Yang, Y.; Zhao, B.; Xu, S. A new dinorspongian diterpene with pyridyl D-ring from the marine sponge Spongia sp. Chin. J. Org. Chem. 2022, 42, 901–904. [Google Scholar] [CrossRef]
  31. Abdelaleem, E.R.; Samy, M.N.; Ali, T.F.S.; Mustafa, M.; Ibrahim, M.A.A.; Bringmann, G.; Ahmed, S.A.; Abdelmohsen, U.R.; Desoukey, S.Y. NS3 helicase inhibitory potential of the marine sponge Spongia irregularis. RSC Adv. 2022, 12, 2992–3002. [Google Scholar] [CrossRef]
  32. Tai, C.-J.; Ahmed, A.F.; Chao, C.-H.; Yen, C.-H.; Hwang, T.-L.; Chang, F.-R.; Huang, Y.M.; Sheu, J.-H. Spongenolactones A–C, bioactive 5,5,6,6,5-pentacyclic spongian diterpenes from the Red Sea sponge Spongia sp. Mar. Drugs 2022, 20, 498. [Google Scholar] [CrossRef]
  33. Tai, C.-J.; Chao, C.-H.; Ahmed, A.F.; Yen, C.-H.; Hwang, T.-L.; Chang, F.-R.; Huang, Y.M.; Sheu, J.-H. New 3,4-seco-3,19-dinor- and spongian-based diterpenoid lactones from the marine sponge Spongia sp. Int. J. Mol. Sci. 2023, 24, 1252. [Google Scholar] [CrossRef]
  34. Yang, I.; Nam, S.-J.; Kang, H. Two new scalaranes from a Korean marine sponge Spongia sp. Nat. Prod. Sci. 2015, 21, 289–292. [Google Scholar] [CrossRef]
  35. Phan, C.S.; Kamada, T.; Hamada, T.; Vairappan, C.S. Cytotoxic sesterterpenoids from Bornean sponge Spongia sp. Rec. Nat. Prod. 2018, 12, 643–647. [Google Scholar] [CrossRef]
  36. Yang, I.; Lee, J.; Lee, J.; Hahn, D.; Chin, J.; Won, D.H.; Ko, J.; Choi, H.; Hong, A.; Nam, S.-J.; et al. Scalalactams A–D, scalarane sesterterpenes with a γ-lactam moiety from a Korean Spongia sp. marine sponge. Molecules 2018, 23, 3187. [Google Scholar] [CrossRef]
  37. Shin, A.-Y.; Lee, H.-S.; Lee, J. Isolation of scalimides A–L: β-alanine-bearing scalarane analogs from the marine sponge Spongia sp. Mar. Drugs 2022, 20, 726. [Google Scholar] [CrossRef]
  38. Hertzer, C.; Kehraus, S.; Böhringer, N.; Kaligis, F.; Bara, R.; Erpenbeck, D.; Wörheide, G.; Schäberle, T.F.; Wägele, H.; König, G.M. Antibacterial scalarane from Doriprismatica stellata nudibranchs (Gastropoda, Nudibranchia), egg ribbons, and their dietary sponge Spongia cf. agaricina (Demospongiae, Dictyoceratida). Beilstein J. Org. Chem. 2020, 16, 1596–1605. [Google Scholar] [CrossRef]
  39. Chaikina, E.L.; Utkina, N.K.; Anisimov, M.M. Influence of merosesquiterpenoids from marine sponges on seedling root growth of agricultural plants. Nat. Prod. Commun. 2016, 11, 11–12. [Google Scholar] [CrossRef] [PubMed]
  40. Li, J.; Gu, B.-B.; Sun, F.; Xu, J.-R.; Jiao, W.-H.; Yu, H.-B.; Han, B.-N.; Yang, F.; Zhang, X.-C.; Lin, H.-W. Sesquiterpene quinones/hydroquinones from the marine sponge Spongia pertusa Esper. J. Nat. Prod. 2017, 80, 1436–1445. [Google Scholar] [CrossRef] [PubMed]
  41. Tang, J.; Wu, W.; Yang, F.; Liu, L.; Yang, Z.; Liu, L.; Tang, W.; Sun, F.; Lin, H. Marine sponge-derived smenospongine preferentially eliminates breast cancer stem-like cells via p38/AMPKα pathways. Cancer Med. 2018, 7, 3965–3976. [Google Scholar] [CrossRef]
  42. Nguyen, H.M.; Ito, T.; Win, N.N.; Kodama, T.; Hung, V.Q.; Nguyen, H.T.; Morita, H. New antibacterial sesquiterpene aminoquinones from a Vietnamese marine sponge of Spongia sp. Phytochem. Lett. 2016, 17, 288–292. [Google Scholar] [CrossRef]
  43. Nguyen, H.M.; Ito, T.; Kurimoto, S.-i.; Ogawa, M.; Win, N.N.; Hung, V.Q.; Nguyen, H.T.; Kubota, T.; Kobayashi, J.i.; Morita, H. New merosesquiterpenes from a Vietnamese marine sponge of Spongia sp. and their biological activities. Bioorg. Med. Chem. Lett. 2017, 27, 3043–3047. [Google Scholar] [CrossRef]
  44. Tian, Y.; Xu, B.; Wang, J.; Lin, H.; Yang, L.; Yang, F. Chemical constituents from Spongia sp., a marine sponge in Xisha Islands. J. Pharm. Pract. 2017, 35, 315–320+382. [Google Scholar] [CrossRef]
  45. Ito, T.; Nguyen, H.M.; Win, N.N.; Vo, H.Q.; Nguyen, H.T.; Morita, H. Three new sesquiterpene aminoquinones from a Vietnamese Spongia sp. and their biological activities. J. Nat. Med. 2018, 72, 298–303. [Google Scholar] [CrossRef]
  46. Orfanoudaki, M.; Hartmann, A.; Alilou, M.; Mehic, N.; Kwiatkowski, M.; Jöhrer, K.; Nguyen Ngoc, H.; Hensel, A.; Greil, R.; Ganzera, M. Cytotoxic compounds of two demosponges (Aplysina aerophoba and Spongia sp.) from the Aegean Sea. Biomolecules 2021, 11, 723. [Google Scholar] [CrossRef]
  47. Tang, W.-Z.; Zhao, H.-M.; Tian, Y.; Dai, S.-W.; Zhang, A.; Lin, H.-W.; Zhang, C.-X.; Yang, F. Merosesquiterpenes from the marine sponge Spongia pertusa Esper and their antifungal activities. Tetrahedron Lett. 2022, 93, 153690. [Google Scholar] [CrossRef]
  48. Hitora, Y.; Takada, K.; Ise, Y.; Woo, S.P.; Inoue, S.; Mori, N.; Takikawa, H.; Nakamukai, S.; Okada, S.; Matsunaga, S. Metachromins X and Y from a marine sponge Spongia sp. and their effects on cell cycle progression. Bioorg. Med. Chem. 2020, 28, 115233. [Google Scholar] [CrossRef]
  49. Bauvais, C.; Bonneau, N.; Blond, A.; Pérez, T.; Bourguet-Kondracki, M.-L.; Zirah, S. Furanoterpene diversity and variability in the marine sponge Spongia officinalis, from untargeted LC–MS/MS metabolomic profiling to furanolactam derivatives. Metabolites 2017, 7, 27. [Google Scholar] [CrossRef]
  50. Abdjul, D.B.; Yamazaki, H.; Kanno, S.-i.; Wewengkang, D.S.; Rotinsulu, H.; Sumilat, D.A.; Ukai, K.; Kapojos, M.M.; Namikoshi, M. Furanoterpenes, new types of protein tyrosine phosphatase 1B inhibitors, from two Indonesian marine sponges, Ircinia and Spongia spp. Bioorg. Med. Chem. Lett. 2017, 27, 1159–1161. [Google Scholar] [CrossRef]
  51. Sun, D.-Y.; Yao, L.-G.; Han, G.-Y.; Guo, Y.-W. Investigation on chemical constituents of Spongia officinalis off Weizhou Island. Chin. J. Mar. Drugs 2017, 36, 1–5. [Google Scholar] [CrossRef]
  52. Sun, D.-Y.; Han, G.-Y.; Yang, N.-N.; Lan, L.-F.; Li, X.-W.; Guo, Y.-W. Racemic trinorsesquiterpenoids from the Beihai sponge Spongia officinalis: Structure and biomimetic total synthesis. Org. Chem. Front. 2018, 5, 1022–1027. [Google Scholar] [CrossRef]
  53. Yang, I.; Choi, H.; Nam, S.-J.; Kang, H. Two indole-alkaloids from a Korean marine sponge Spongia sp. Bull. Korean Chem. Soc. 2015, 36, 2120–2123. [Google Scholar] [CrossRef]
  54. Zhang, Y.-F.; Li, D.C.; Liao, X.-J.; Xu, S.-H.; Zhao, B.-X. Spongimides A and B, two new alkaloids from the marine sponge Spongia sp. J. Asian Nat. Prod. Res. 2023, 25, 1044–1050. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Sesquiterpenes obtained from the genus Spongia.
Figure 1. Sesquiterpenes obtained from the genus Spongia.
Marinedrugs 22 00213 g001
Figure 2. Diterpenes obtained from the genus Spongia.
Figure 2. Diterpenes obtained from the genus Spongia.
Marinedrugs 22 00213 g002aMarinedrugs 22 00213 g002bMarinedrugs 22 00213 g002cMarinedrugs 22 00213 g002d
Figure 3. Sesterterpenes obtained from the genus Spongia.
Figure 3. Sesterterpenes obtained from the genus Spongia.
Marinedrugs 22 00213 g003
Figure 4. Meroterpenes obtained from the genus Spongia.
Figure 4. Meroterpenes obtained from the genus Spongia.
Marinedrugs 22 00213 g004aMarinedrugs 22 00213 g004bMarinedrugs 22 00213 g004c
Figure 5. Linear furanoterpenoids obtained from the genus Spongia.
Figure 5. Linear furanoterpenoids obtained from the genus Spongia.
Marinedrugs 22 00213 g005
Figure 6. Steroids obtained from the genus Spongia.
Figure 6. Steroids obtained from the genus Spongia.
Marinedrugs 22 00213 g006
Figure 7. Alkaloids obtained from the genus Spongia.
Figure 7. Alkaloids obtained from the genus Spongia.
Marinedrugs 22 00213 g007
Figure 8. Other miscellaneous compounds obtained from the genus Spongia.
Figure 8. Other miscellaneous compounds obtained from the genus Spongia.
Marinedrugs 22 00213 g008
Figure 9. Chemical profile of secondary metabolites from the genus Spongia.
Figure 9. Chemical profile of secondary metabolites from the genus Spongia.
Marinedrugs 22 00213 g009
Figure 10. Reported compounds from different species of the genus Spongia.
Figure 10. Reported compounds from different species of the genus Spongia.
Marinedrugs 22 00213 g010
Figure 11. Annually reported compounds from the genus Spongia.
Figure 11. Annually reported compounds from the genus Spongia.
Marinedrugs 22 00213 g011
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Yang, Q.-B.; Liang, L.-F. Spongia Sponges: Unabated Sources of Novel Secondary Metabolites. Mar. Drugs 2024, 22, 213. https://doi.org/10.3390/md22050213

AMA Style

Yang Q-B, Liang L-F. Spongia Sponges: Unabated Sources of Novel Secondary Metabolites. Marine Drugs. 2024; 22(5):213. https://doi.org/10.3390/md22050213

Chicago/Turabian Style

Yang, Qi-Bin, and Lin-Fu Liang. 2024. "Spongia Sponges: Unabated Sources of Novel Secondary Metabolites" Marine Drugs 22, no. 5: 213. https://doi.org/10.3390/md22050213

APA Style

Yang, Q. -B., & Liang, L. -F. (2024). Spongia Sponges: Unabated Sources of Novel Secondary Metabolites. Marine Drugs, 22(5), 213. https://doi.org/10.3390/md22050213

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop